RFK Jr. confronts ‘Deep State’ at FDA, calls agency ‘sock puppet’ of industries: report

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. made a surprising visit to the FDA on Friday, where he reportedly discussed the existence of the “Deep State.” The visit marked his first appearance alongside FDA Commissioner Marty Makary and was intended to welcome the new chief.

Kennedy’s remarks about the Deep State were captured in an audio recording obtained by Politico. He emphasized that the Deep State is a real entity and not just a conspiracy theory involving prominent individuals like George Soros and Bill Gates. Kennedy pointed to “institutional pressures” as a key factor contributing to the influence of the Deep State.

During his visit, Kennedy also criticized the FDA, accusing the agency of being a “sock puppet” for the industries it is supposed to regulate. This sentiment was echoed in a report by NBC News, where Kennedy highlighted systemic issues within the FDA and other government agencies.

One specific area of concern for Kennedy is the FDA’s Generally Recognized as Safe (GRAS) system, which he believes allows food companies to exploit loopholes in the approval process for new ingredients. In a bid to address this issue, Kennedy directed the FDA to reevaluate its policies on food additives, aiming to enhance transparency and safeguard public health.

Kennedy’s vocal criticism of the FDA is not new, as he has consistently advocated for reforms to improve the health of Americans. Leading up to the 2024 election, Kennedy issued warnings to FDA employees involved in what he described as a corrupt system, urging them to preserve their records and prepare for change.

In a recent MAHA (Make America Healthy Again) tour across several states, Kennedy focused on advocating for regulations banning unhealthy additives in school lunches. This tour underscored his commitment to promoting healthier eating habits and addressing the influence of powerful industries on public health.

As reports of Kennedy’s visit to the FDA continue to circulate, it remains to be seen how his efforts to challenge the status quo will shape the future of health policy in the United States. Fox News Digital reached out to HHS for comment on these developments but did not receive a response at the time of publication.

This article was rewritten based on the original content from Fox News Digital, maintaining the key points and references to HTML tags and headings.